Product correctly added to cart.

Standards and Solutions in Compliance with Pharmacopoeias
Standards and Solutions in Compliance with Pharmacopoeias

Standards and Solutions in Compliance with Pharmacopoeias

Standards and solutions in compliance with pharmacopoeias are essential reference materials used to ensure the quality, safety, and efficacy of pharmaceutical products. This category includes a wide range of solutions and reagents that adhere to the stringent requirements set forth by various pharmacopoeias, such as the European Pharmacopoeia (EP) and the British Pharmacopoeia (BP). These standards are critical for the calibration and validation of analytical methods, ensuring that pharmaceutical products meet regulatory standards. They support a broad spectrum of applications, including the analysis of active pharmaceutical ingredients (APIs), excipients, and finished drug products. By providing consistent and reliable reference points, these standards and solutions facilitate compliance with regulatory requirements, enhance quality control processes, and ensure the production of safe and effective pharmaceuticals. Their use is indispensable in pharmaceutical research, development, and manufacturing, ensuring that products adhere to the highest quality standards.

Read more

Products of "Standards and Solutions in Compliance with Pharmacopoeias"

Sort by


See more categories

This search does not contain any category.

products per page. 4400 products on this category.

BrandProduct dataPurityPrice rangeEstimated delivery
EDQM - European Pharmacopoeia logo
Hyoscine hydrobromide CRS
REF: 41-H1500000
CAS: 6533-68-2
- - -115.00 €Fri 03 Jan 25
British Pharmacopoeia logo
Bisacodyl
REF: 47-47
CAS: 603-50-9
99.5%242.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Somatostatin CRS
REF: 41-S0945000
CAS: 38916-34-6
- - -137.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Pregabalin CRS
REF: 41-Y0001805
CAS: 148553-50-8
- - -115.00 €Fri 03 Jan 25
British Pharmacopoeia logo
Acitretin
REF: 47-827
CAS: 55079-83-9
100.0%242.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Amlodipine impurity G CRS
REF: 41-Y0001070
CAS: 43067-01-2
- - -115.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Lauric acid CRS
REF: 41-Y0001474
CAS: 143-07-7
- - -115.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Phenytoin sodium CRS
REF: 41-P1300000
CAS: 630-93-3
- - -115.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
(25R)-Spirost-5-en-3-one CRS
REF: 41-Y0001879
CAS: 20817-62-3
- - -115.00 €Fri 03 Jan 25
British Pharmacopoeia logo
Bupivacaine hydrochloride
REF: 47-479
CAS: 73360-54-0
94.8%242.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Mestranol CRS
REF: 41-M0600000
CAS: 72-33-3
- - -115.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Maleic acid CRS
REF: 41-M0100000
CAS: 110-16-7
- - -115.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Ticagrelor CRS
REF: 41-Y0002222
CAS: 274693-27-5
- - -115.00 €Fri 03 Jan 25
British Pharmacopoeia logo
Pravastatin impurity A
REF: 47-1030
CAS: 250737-12-3
- - -211.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Piperacillin impurity N CRS
REF: 41-Y0002241
- - -115.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Poloxamer 338 CRS
REF: 41-P2164021
CAS: 9003-11-6
- - -115.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Methylaminolevulinate impurity C CRS
REF: 41-Y0002279
- - -115.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Cefoperazone sodium - reference spectrum
REF: 41-C0684800
- - -115.00 €Fri 03 Jan 25
British Pharmacopoeia logo
1,4-bis(4-chlorobenzhydryl)piperazine
REF: 47-441
CAS: 346451-15-8
- - -211.00 €Fri 03 Jan 25
EDQM - European Pharmacopoeia logo
Milbemycin oxime CRS
REF: 41-Y0001893
CAS: 129496-10-2
- - -115.00 €Fri 03 Jan 25
discount label

Hyoscine hydrobromide CRS


Ref: 41-H1500000

50mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Bisacodyl


Ref: 47-47

100mg242.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Somatostatin CRS


Ref: 41-S0945000

2.09mg137.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Ref: 41-Y0001805

250mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Acitretin


Ref: 47-827

100mg242.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Ref: 41-Y0001070

10mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Lauric acid CRS


Ref: 41-Y0001474

1500mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Phenytoin sodium CRS


Ref: 41-P1300000

250mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Ref: 41-Y0001879

10mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Bupivacaine hydrochloride


Ref: 47-479

100mg242.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Mestranol CRS


Ref: 41-M0600000

100mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Maleic acid CRS


Ref: 41-M0100000

100mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Ref: 41-Y0002222

120mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Pravastatin impurity A


Ref: 47-1030

10mg211.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Ref: 41-Y0002241

15mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Poloxamer 338 CRS


Ref: 41-P2164021

100mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Ref: 41-Y0002279

30mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Ref: 41-C0684800

1u115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Ref: 47-441

25mg211.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
discount label

Ref: 41-Y0001893

110mg115.00 €
Estimated delivery in United States, on Friday 3 Jan 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".